U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN
7194H8W3KT
US Approved Rx (2000)
First approved in 1994
General
Record Details
Variant Concepts
1
Names
3
Classification
3
Identifiers
11
Display Structure
Relationships
2
Active Moiety
1
Modifications
1
Characteristic Attributes
1
SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN
7194H8W3KT
US Approved Rx (2000)
First approved in 1994
General
Approval Year
1994
152
Record Details
Substance Class
Polymer
Record UNII
7194H8W3KT
Record Status
FAILED
Record Version
22
21
20
19
18
17
16
15
14
13
12
11
10
9
8
7
6
5
4
3
2
1
Show
5
20
100
All
entries
Related Record
Type
Related Record
Type
ALTERNATIVE DEFINITION for [SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN]
Alternative Definition
Showing 1 to 1 of 1 entries
Previous
1
Next
Names
3
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN
Common Name
English
SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI TY2 VI POLYSACCHARIDE ANTIGEN
Preferred Name
English
SALMONELLA TYPHI TY2 POLYSACCHARIDE ANTIGEN, A
Common Name
English
Showing 1 to 3 of 3 entries
Previous
1
Next
Classification
3
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Established Pharmacologic Class
Established Pharmacologic Class
[EPC]
Inactivated Salmonella Typhi Vaccine
[EPC]
NDF-RT
N0000183910
Established Pharmacologic Class
Established Pharmacologic Class
[EPC]
Inactivated Salmonella Typhi Vaccine
[EPC]
NDF-RT
N0000183901
Antigen
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Antigen
[C268]
Salmonella Typhi Antigen
NCI_THESAURUS
C75819
Showing 1 to 3 of 3 entries
Previous
1
Next
Identifiers
11
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
NDF-RT
N0000178997
PRIMARY
Vaccines, Typhoid [Chemical/Ingredient]
DAILYMED
7194H8W3KT
PRIMARY
NDF-RT
N0000179280
PRIMARY
Vi polysaccharide vaccine, typhoid [Chemical/Ingredient]
EVMPD
SUB12387MIG
ALTERNATIVE
NDF-RT
N0000183364
PRIMARY
Actively Acquired Immunity [PE]
Showing 1 to 5 of 11 entries
Previous
1
2
3
Next
Display Structure
Export Data
Relationships
2
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
TYPHOID VI POLYSACCHARIDE VACCINE
SUB_CONCEPT->SUBSTANCE
Amount:
760T5R8B3O
SALMONELLA ENTERICA ENTERICA SEROVAR TYPHI
TARGET ORGANISM->VACCINE ANTIGEN
Amount:
Showing 1 to 2 of 2 entries
Previous
1
Next
Active Moiety
1
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
7194H8W3KT
SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN
ACTIVE MOIETY
Amount:
Showing 1 to 1 of 1 entries
Previous
1
Next
Modifications
1
Structural Modifications
Show
5
20
100
All
entries
Modification Type
Location Site
Location Type
Residue Modified
Extent
Fragment Name
Fragment Approval
Modification Type
Location Site
Location Type
Residue Modified
Extent
Fragment Name
Fragment Approval
DEACYLATION
3-O-DEACYLATION
Amount:
SITE OCCUPIED 88 % [>50] (average)
UNSPECIFIED SUBSTANCE
76601573
(not in database)
Showing 1 to 1 of 1 entries
Previous
1
Next
Characteristic Attributes
1
Name
Property Type
Amount
Referenced Substance
Defining
Parameters
References
MOL_WEIGHT:WEIGHT AVERAGE
CHEMICAL
[>200000] (average)
![ALTERNATIVE DEFINITION for [SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN]](https://drugs.ncats.io/assets/ginas/images/structurallyDiverse.svg "ALTERNATIVE DEFINITION for [SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN]")
